Awz Ventures primarily focuses on investing in commercial and defensive applications of security and intelligence technologies, especially those powered by Artificial Intelligence. Their strategy, known as "Active Capital," involves providing hands-on support, mentorship, and strategic guidance to their portfolio companies from inception through to global success and liquidity opportunities.
33% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (50% of deals). Average disclosed round size is $21.2M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$500M
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Promise Bio | Seed | $8.3M | Dec 2024 |
 NanoPass Technologies | Series A | $6M | Jul 2024 |
| MMagnus Metal | Series B | $74M | Apr 2024 |
| KKTrust | Seed | $5.4M | Feb 2024 |
| Promise Bio | Seed | $8.3M | Apr 2023 |
 Pcysys | Series B | $25M | Sep 2020 |
Top Co-Investors
Pfizer Ventures2 shared
Target Global1 shared
Caterpillar1 shared
Deep Insight1 shared
Lumir1 shared
Discount Capital1 shared
Cresson Management1 shared
Next Gear Ventures1 shared
Essentia Venture Capital1 shared
Insight Partners1 shared
AstraZeneca1 shared
Last updated: 13 March 2026